To blame the healthcare system is what Mylan CEO Heather Bresch told CNBC today in explaining why the price of her company's EpiPen has seen price hikes of 400%. CNBC's Meg Tirrell breaks down the pharma supply chain system.
CNBC's Meg Tirrell reports on the Pharmaceutical Care Management Association's response to Mylan blaming "the middlemen" for its EpiPen price hike.
The "FMHR" traders; Sarat Sethi, Douglas C. Lane & Associates; and Stephanie Link, TIAA Global Asset Management, reveal their final trades, including CVS, Square and more.
Jim Cramer analyzed the winners and losers in retail for the quarter and discovered an interesting trend.
"It's going to take awhile for Target to turn this around," one analyst told CNBC.
Citing a "difficult" retail environment, Target lowers its guidance for the full year.
CVS Health's new "excluded" list includes medications used in treatment of patients with cancer, diabetes and hepatitis C.
CNBC's Melissa Lee looks at good, bad and ugly stocks, including CVS and Generac.
Some of the names on the move ahead of the open.
Amazon's outperformance is stunning when compared with the retailers its online strategies have been crushing.
Mark Spellman, Alpine Funds Co-Portfolio Manager, explains his views on finding yield in large-cap stocks over mid-caps and gives his picks.
As online viewers grow up, they're looking for digital shows that suit their needs. And this is also changing advertising as we know it.
Morgan Stanley just downgraded CVS to equal weight from overweight.
Shares of Walgreens and Rite Aid skyrocketed around 4 percent amid reports that the FTC is likely to approve Walgreens' acquisition of Rite Aid.
Jim Cramer shares his opinion on various caller stocks, including this player in the oil patch that could be influenced by OPEC.
Michael Farr, Farr Miller & Washington, and Kevin Norris, Univest Wealth Management President, discuss their summer market outlooks and give their picks.
Jim Cramer gives his opinion to callers on various stocks, including the deal between Rite Aid and Walgreens.
The Fast Money traders discuss the brutal week for retail and share how to play the space. Also, a look at the auto sector.
Amid the wreckage in the retail sector, is now the time to cherry-pick some of the names that may have been unfairly punished?
Prominent investor Susan Byrne significantly reduced her stake in Apple for the Platinum Portfolio.